SE204939C1 - - Google Patents

Info

Publication number
SE204939C1
SE204939C1 SE204939DA SE204939C1 SE 204939 C1 SE204939 C1 SE 204939C1 SE 204939D A SE204939D A SE 204939DA SE 204939 C1 SE204939 C1 SE 204939C1
Authority
SE
Sweden
Prior art keywords
poliomyelitis
virus
combination
aqueous medium
vaccine
Prior art date
Application number
Other languages
English (en)
Swedish (sv)
Publication date
Publication of SE204939C1 publication Critical patent/SE204939C1/sv

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE204939D SE204939C1 (Sortimente)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE204939T

Publications (1)

Publication Number Publication Date
SE204939C1 true SE204939C1 (Sortimente) 1965-01-01

Family

ID=41988314

Family Applications (1)

Application Number Title Priority Date Filing Date
SE204939D SE204939C1 (Sortimente)

Country Status (1)

Country Link
SE (1) SE204939C1 (Sortimente)

Similar Documents

Publication Publication Date Title
US3019168A (en) Heat and ultra-violet light attenuation of polio virus
RU2710239C1 (ru) Способ получения антигена или антигенов для производства противогриппозной вакцины и вакцина на его основе
US8703467B2 (en) Inactivation of a pathogen in a sample by a treatment with formalin and UV light
CA2567336C (en) Inactivation of a pathogen in a sample by a treatment with formalin and uv light
CN105949307A (zh) 一种用于防治番鸭源小鹅瘟的卵黄抗体
US2421382A (en) Vaccines and antigens and method of producing the same
SE204939C1 (Sortimente)
US2705696A (en) Production of antigens
GB655198A (en) Process and apparatus for the irradiation of liquids
US2720485A (en) Preparation of concentrated, purified ultraviolet inactivated hog cholera vaccine
CN105193721B (zh) 一种禽用纳米级油包水型灭活疫苗制备方法
CN112999343B (zh) 一种鹅星状病毒的灭活疫苗及其制备方法
NO120204B (Sortimente)
Polley Preparation of non-infective soluble antigens with gamma radiation
CN212973633U (zh) 一种用于动物血液病毒灭活的装置
US3076748A (en) Poliomyelitis virus attenuation with ultraviolet light and beta propiolactone
RU2255766C2 (ru) Способ получения иммуноглобулинового препарата для профилактики и терапии бактериальных и вирусных инфекций, иммуноглобулиновый препарат для профилактики и терапии бактериальных и вирусных инфекций (варианты) и суппозитории на основе иммуноглобулинового препарата
Fellowes Comparison of the Inactivation and Antigenicity of Foot-and-Mouth-Disease Virus by Acetylethyleneimine and by Combined Effect of Ultraviolet Light and β-Propiolactone
JP4132151B2 (ja) プリオンの不活化方法
RU2822827C1 (ru) Способ получения препарата вакцины из цельных вирусов или бактерий
DE1003398B (de) Verfahren zur Herstellung von Poliomyelitis-Virus-Vaccine
DE1037655B (de) Verfahren zur Herstellung von Impfloesungen mit abgetoetetem infektioesem Hepatitisvirus
WO2024191324A1 (ru) Способ получения препарата вакцины из цельных вирусов или бактерий
Polley et al. Preparation of a stable non-infective western equine encephalomyelitis virus antigen from allantoic fluid
CA2716426A1 (en) Inactivation of a pathogen in a sample by a treatment with formalin and uv light